Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin and Flutamide with Radiotherapy in Prostate Cancer
NCT00104741Phase 3Completed
- Sponsor
- Unicancer
- Start
- Sep 2003
- Primary completion
- Oct 2015
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin, flutamide in prostate cancer (PCa), sponsored by Unicancer. Started Sep 2003; status: completed.
02
Drugs
triptorelinflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00104741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104741.